Skip to main content

Month: July 2023

Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook

Ad hoc announcement pursuant to Art. 53 LRU.S. District Court for the District of Delaware ruled the Entresto (sacubitril / valsartan) ‘combination patent’ to be invalid Novartis will appeal to the U.S. Court of Appeals for the Federal Circuit to reverse the District Court’s ruling No generic Entresto product has received FDA approval as of today Pending a final appeal decision and other ongoing litigation involving multiple patents, any launch once generics receive FDA approval would be ‘at risk’ Novartis maintains confidence in short and mid-term growth, maintains 2023 guidance and mid-term outlookBasel, July 07, 2023 — Novartis today announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent covering Entresto and combinations of sacubitril and valsartan, which...

Continue reading

Nokia Corporation: Repurchase of own shares on 07.07.2023

Nokia CorporationStock Exchange Release7 July 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 07.07.2023 Espoo, Finland – On 7 July 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 290,034 3.83CEUX 52,322 3.83AQEU 7,701 3.83TQEX 17,943 3.83Total 368,000 3.83* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Golar LNG Limited – Q2 2023 results presentation

Golar LNG’s 2nd Quarter 2023 results will be released before the NASDAQ opens on Thursday, August 10, 2023. In connection with this a webcast presentation will be held at 1:00 P.M (London Time) on Thursday August 10, 2023. The presentation will be available to download from the Investor Relations section at www.golarlng.com We recommend that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call by clicking on this link. We recommend connecting 10 minutes prior to the call start. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions per participant. a....

Continue reading

Gladiator Metals Announces Closing of Second Tranche of Private Placement for Total of $6.8 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S. VANCOUVER, British Columbia, July 07, 2023 (GLOBE NEWSWIRE) — Gladiator Metals Corp. (TSXV: GLAD / OTC Markets: GDTRF / FSE: ZX7) (“Gladiator” or the “Company”), is pleased to announce that it has closed the second tranche of its previously announced brokered private placement offering (the “Offering”) consisting of 5,908,728 flow-through units of the Company sold to charitable purchasers (the “Charity FT Units”) at a price of $0.7975 per Charity FT Unit for gross proceeds of approximately $4.7 million. The Offering was led by Research Capital Corporation as lead agent and sole bookrunner (the “Lead Agent”), on behalf of a syndicate of agents, including Beacon Securities Limited (together with the Lead Agent, the “Agents”). The aggregate gross proceeds...

Continue reading

Groupe Casino: Extension of 3F Holding’s offer

Extension of 3F Holding’s offer Paris, 7 July 2023 Casino announces that 3F Holding has extended the validity of its offer, filed on July 4 2023, to 10 July 2023. *** This press release was prepared solely for information purposes and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments. Likewise, it does not provide and should not be treated as providing investment advice. It has no connection with the specific investment objectives, financial situation or needs of any receiver. No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein. Recipients should not consider it as a substitute for the exercise of their own judgement. All the opinions expressed herein are subject to...

Continue reading

Narcolepsy Drugs Market to Worth USD 6115.61 Million by 2030 | Skyquest Technology

Narcolepsy drugs market is segmented based on the narcolepsy type, therapeutics and end user. Regarding narcolepsy type, the market is segmented into cataplexy and extreme daytime sleepiness. On the basis of therapeutics, the narcolepsy drugs market is categorized into psychostimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitors, and central nervous system stimulants. The end user segment is further classified into hospitals and diagnostic centres- Industry Forecast 2023-2030 Westford, USA, July 07, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the narcolepsy drugs market is primarily driven by the ageing population worldwide, as they are more vulnerable to chronic and acute diseases requiring ongoing medical care. The increasing prevalence of chronic conditions such as diabetes, cardiovascular...

Continue reading

Societe Generale: Half-Year statement on the Liquidity agreement

HALF-YEAR STATEMENT ON THE LIQUIDITY AGREEMENT Regulated Information Paris, 07 July 2023 Half-year statement and information about the number of executed transactions and the exchanged volume regarding the liquidity agreement of SOCIETE GENERALE. Under the liquidity agreement signed between Societe Generale and Rothschild Martin Maurel, the following assets were held by the liquidity account as of 30 June 2023:6,000 shares € 4,944,463.00As a reminder, on the last half-year liquidity contract statement as of 31 December 2022, the following assets were allocated to the liquidity account:0 share € 5,016,581.00The following information presents the number of transactions executed on purchases and sales, as well as the volume exchanged on purchases and sales in shares number and in capital from 01 January to 30 June 2023 within the...

Continue reading

Sogeclair: Voting rights as at 2023/06/30

SOGECLAIRBusiness corporation with a capital of 3 204 901 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSEInformation concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (‘“Règlement général de l’Autorité des Marchés Financiers”)DATE Total number of shares in the share capital Total number of voting rights30 June 2023 3,204,901 Total voting rights – brut: 5,405,960    Total voting rights – net*: 5,248,574* net total: total number of voting rights attached to the total number of shares – shares deprived of voting rights (treasury stock etc.)         ...

Continue reading

EMGS – Vessel activity and multi-client sales update for the second quarter 2023

Electromagnetic Geoservices ASA (the “Company” or “EMGS”) releases information on vessel activity and multi-client sales during the quarter approximately 4-5 working days after the close of each quarter. The Company defines vessel utilisation as the percentage of the vessel charter period spent on proprietary or multi-client data acquisition. Downtime (technical or maritime), mobilisation, steaming, and some standby activities are not included in the utilisation rate.   At the end of the second quarter 2023 the Company had one vessel on charter, the Atlantic Guardian. The Atlantic Guardian was warm stacked for the entire quarter.     The utilization for the second quarter was 0% compared with 18% for the second quarter 2022.  EMGS had one vessel in operation and recorded 3.0 vessel months in the quarter. In the second quarter 2022, the...

Continue reading

Firm Capital Property Trust Completes $38.2 Million Mortgage Refinancing of Pointe-Claire Multi-Residential Property and Provides Stability and Compelling Value

TORONTO, July 07, 2023 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust”) (TSX: FCD.UN) is pleased to announce the following: $38.2 MILLION, 3.69%, 10-YEAR MORTGAGE REFINANCINGThe Trust has closed a $38.2 million mortgage refinancing of its 100% owned Multi-Residential Property located in Pointe-Claire, QC. The CMHC insured mortgage has a 3.69% fixed interest rate, 40-year amortization and a ten-year term. The previous bridge mortgage had a 7.02% effective interest rate. As a result of the refinancing, the Trust will reduce its annual interest expense by approximately $1.3 million representing a savings of $0.035 per unit. The Trust has now refinanced all 2023 maturities except for one $2.4 million mortgage. BALANCE SHEET STABILITY The Trust is focused on maintaining a strong balance sheet to mitigate risks:A...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.